Okereke Melody
Faculty of Pharmaceutical Sciences, University of Ilorin, Kwara State, Nigeria.
Innov Pharm. 2022 Apr 2;13(1). doi: 10.24926/iip.v13i1.4466. eCollection 2022.
Despite a population of over 89 million people, the Democratic Republic of Congo (DRC) has just 30 local pharmaceutical manufacturers (DRC) with the majority of manufacturers based in Kinshasa, the capital city. Of the total number of pharmaceutical products sold in the DRC, just 10% accounts for those manufactured locally. The DRC remains dependent on other countries such as China and India for the supply of active pharmaceutical ingredients (APIs) -thus, local pharmaceutical manufacturing is therefore reliant on imported commodities and industrial machinery. Given the relevance of the pharmaceutical industry, it is vital to pay careful attention to the problems affecting it. Here, we assess the current situation of pharmaceutical manufacturing in the DRC, examine current challenges, and provide solutions for future development.
尽管刚果民主共和国（DRC）有超过8900万人口，但该国仅有30家本地制药企业，其中大多数企业位于首都金沙萨。在刚果民主共和国销售的药品总数中，只有10%是本地生产的。刚果民主共和国在活性药物成分（API）供应方面仍依赖中国和印度等其他国家，因此，本地制药业依赖进口商品和工业机械。鉴于制药行业的重要性，认真关注影响该行业的问题至关重要。在此，我们评估了刚果民主共和国制药业的现状，审视了当前面临的挑战，并为未来发展提供了解决方案。
